Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Bob Holland


Bob Holland has joined Oxford Gene Technology as its chief medical officer.

Holland previously served as vice president and head of AstraZeneca's Personalized Healthcare and Biomarkers division.

In his new role at OGT, Holland will lead clinical affairs across OGT's business areas. He will work with the UK company's R&D and commercial teams to develop clinical development programs that will expand its next-generation sequencing and microarray cancer profiling solutions. Holland will also work with OGT's biomarker programs for prostate and colorectal cancers, OGT said.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.